Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,116

This is primarily about Rejuvant or AKG trials. When they first reported an 8 year age difference I did not truly believe it as that would mean I could take it, de-age, then age a bit, then just take it again. The tests however are ongoing and will feature people who are biologically older than their calendar age. There is also mention of 110 drugs/supplements that do “something” to mice. That would be quite a stack to take.

Dr Brian Kennedy presents potential interventions for extend our healthspan. Among them, Rejuvant – a CaAKG supplement which contain calcium + alpha-ketoglutarate shows better response for people who has biological age older than chronological age.

The first human trial of Rejuvant to reverse human biological age by 8 years in 7 month.

Rejuvant®, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660611/

Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of delaying, detecting, and preventing human aging and associated diseases. He is a Professor in the Departments of Biochemistry and Physiology at National University Singapore and Director of the Centre for Healthy Ageing in the National University Health System. From 2010 to 2016 he was the President and CEO of the Buck Institute for Research on Aging. Currently, he remains as a Professor at the Institute. Dr. Kennedy also has an adjunct appointment at the USC Davis School of Gerontology. Dr. Kennedy is also actively involved Biotechnology companies, serving in consulting and Board capacities, as well as Scientific Director of Affirmativ Health. Dr. Kennedy also serves as a Co-Editor-In-Chief at Aging Cell.

Continue reading “Potential Interventions For HUMAN LONGEVITY, CaAKG Is More Effective for People w/Accelerating Aging” | >

This included ‘evaluating life’, such as seeing memories and assessing how they had treated others during their time alive.

Others felt like they were ‘heading to a destination’ or were even aware that CPR was being performed.

Dr Sam Parnia, study author and a critical care expert from New York medical centre NYU Langone Health, said patients can also be aware of activities in intensive care after CPR and hear medics treating them.

Read more | >

Summary: Findings could have implications for new avenues of research for a range of neurodegenerative diseases including ALS and Alzheimer’s.

Source: University of Bath.

A discovery that may improve treatment options for patients with neurodegenerative diseases has been made by scientists at King’s College London and the University of Bath in the UK.

Read more | >

We have had extremely positive results from customers who were suffering from Cancer, Heart Disease, High Blood Pressure, High Cholesterol, Thyroid Issues, Arthritis, Fibromyalgia, auto-immune diseases, Crohn’s Disease, Type 2 Diabetes, heavy metal toxicity, viral infections, scar tissue, and more.

Ingredients: Extract of Wild Harvested Shiaqga mushroom, Organic Black Cumin Seed Oil, Sacred Frankincense Oil, Organic Lemon Essential Oil, Organic Cinnamon Bark Essential Oil, and Organic Peppermint Essential Oil

The Rapid Immune Recovery has a 20x stronger concentration of the Shiaqga mushroom than the Daily Immune Restoration and 10X More Sacred Frankincense than Daily Immune Restoration Each bottle is a 30 day supply at 4 ml per day.

Read more | >

Oregon State University scientists have invented a way to make magnetic nanoparticles that get hotter than any previous nanoparticle, improving their cancer fighting ability.

Faculty from the OSU College of Pharmacy spearheaded a collaboration that developed an advanced thermal decomposition method for producing able to reach temperatures in lesions of up to 50 degrees Celsius, or 122 degrees Fahrenheit, when exposed to an alternating magnetic field.

Findings of the preclinical study led by Oleh Taratula and Olena Taratula were published today in the journal Small Methods.

Read more | >

Last year, MIT developed an AI/ML algorithm capable of learning and adapting to new information while on the job, not just during its initial training phase. These “liquid” neural networks (in the Bruce Lee sense) literally play 4D chess — their models requiring time-series data to operate — which makes them ideal for use in time-sensitive tasks like pacemaker monitoring, weather forecasting, investment forecasting, or autonomous vehicle navigation. But, the problem is that data throughput has become a bottleneck, and scaling these systems has become prohibitively expensive, computationally speaking.

On Tuesday, MIT researchers announced that they have devised a solution to that restriction, not by widening the data pipeline but by solving a differential equation that has stumped mathematicians since 1907. Specifically, the team solved, “the differential equation behind the interaction of two neurons through synapses… to unlock a new type of fast and efficient artificial intelligence algorithms.”

“The new machine learning models we call ‘CfC’s’ [closed-form Continuous-time] replace the differential equation defining the computation of the neuron with a closed form approximation, preserving the beautiful properties of liquid networks without the need for numerical integration,” MIT professor and CSAIL Director Daniela Rus said in a Tuesday press statement. “CfC models are causal, compact, explainable, and efficient to train and predict. They open the way to trustworthy machine learning for safety-critical applications.”

Read more | >

What will it take for a same-sex couple—two males or two females—to be able to produce a biological child by combining their genomes in the same way that male-female couples do? Just to be clear, we’re not talking about adopting. Nor do we mean one mate fertilizes a donor egg or is fertilized with donated sperm. Those things have long existed. We mean you take two women or two men and make a baby.

And they’ve already done it with two male mice.

Read more | >

Bringing together concepts from electrical engineering and bioengineering tools, Technion and MIT scientists collaborated to produce cells engineered to compute sophisticated functions— biocomputers of sorts.

Graduate students and researchers from Technion—Israel Institute of Technology Professor Ramez Daniel’s Laboratory for Synthetic Biology & Bioelectronics worked together with Professor Ron Weiss from the Massachusetts Institute of Technology to create genetic “devices” designed to perform computations like artificial neural circuits. Their results were recently published in Nature Communications.

The was inserted into the bacterial cell in the form of a plasmid: a relatively short DNA molecule that remains separate from the bacteria’s “natural” genome. Plasmids also exist in nature, and serve various functions. The research group designed the plasmid’s genetic sequence to function as a simple computer, or more specifically, a simple artificial neural network. This was done by means of several genes on the plasmid regulating each other’s activation and deactivation according to outside stimuli.

Read more | >

Synopsis: In this talk we articulate a positive vision of the future that is both viable given what we know, and also utterly radical in its implications. We introduce two key insights that, when taken together, synergize in powerful ways. Namely, (a) the long-tails of pleasure and pain, and (b) the correlation between wellbeing, productivity, and intelligence. This informs us how to distribute resources if we want to maximize wellbeing. Given the weight of the extremes, it is important to take them into account. But because of the causal significance of more typical hedonic ranges, engineering our baseline is a key consideration. This makes it natural to break down the task of paradise engineering into three components:

Avoid negative extremes.
increase hedonic baseline, and.
achieve new heights of experience.

With regards to : the future of consciousness is anodyne. It lacks extreme suffering in any of its guises. We will see how, if we aim right, a significant proportion of extreme suffering can be prevented with pragmatic technologies already available. Even just applying what we know today would be as significant for the reduction of suffering as the advent of anesthesia was in the context of surgery.

On : the future of consciousness is engaging. From novelty generation to Buddhist annealing, baseline-enhancing interventions will change the way we think of life. It is not only about making everyday fun, but also the economics of it.

And : the future of consciousness is ecstatic. A science of ecstasy will allow us to safely and reliably sample from a wide range of time-tested ultra-blissful peak experiences. A common cause with other sentient beings, and indeed with the interests of consciousness at large, can be forged in the knowledge of such deep experiences.

They give you a genuine, non-sentimental, reason to live. Together, action on these three levels can significantly advance the cause of eliminating suffering and engineering paradise. And our assessment is: there is a lot of low-hanging fruit in this space. Let’s pick it up!

Continue reading “The Future of Consciousness — Andrés Gómez Emilsson” | >